Fetomaternal alloimmune thrombocytopenia: The questions that still remain
Authors:
- 1 January 2007
- journal article
- review article
- Published by Taylor & Francis in The Journal of Maternal-Fetal & Neonatal Medicine
- Vol. 20 (9) , 633-637
Abstract
Fetomaternal alloimmune thrombocytopenia (FMAIT) occurs when maternal antibodies are formed to fetal platelet antigens, leading to thrombocytopenia and hemorrhagic complications. The diagnosis is frequently made only after a major hemorrhagic event has occurred during a pregnancy. Identifying patients at risk remains difficult, and the optimal treatment regimen remains to be determined.Keywords
This publication has 25 references indexed in Scilit:
- Management and outcome of 200 cases of fetomaternal alloimmune thrombocytopeniaTransfusion, 2007
- Cost‐effectiveness of antenatal screening for neonatal alloimmune thrombocytopeniaBJOG: An International Journal of Obstetrics & Gynaecology, 2007
- Parallel Randomized Trials of Risk-Based Therapy for Fetal Alloimmune ThrombocytopeniaObstetrics & Gynecology, 2006
- Chronic villitis in untreated neonatal alloimmune thrombocytopenia: An etiology for severe early intrauterine growth restriction and the effect of intravenous immunoglobulin therapyAmerican Journal of Obstetrics and Gynecology, 2005
- Experiences with fetomaternal alloimmune thrombocytopenia at a Swedish hospital over a 10‐year periodActa Obstetricia et Gynecologica Scandinavica, 2003
- Will it ever be possible to balance the risk of intracranial haemorrhage in fetal or neonatal alloimmune thrombocytopenia against the risk of treatment strategies to prevent it?Vox Sanguinis, 2003
- Gene frequencies of the five major human platelet antigens in African American, white, and Korean populationsTransfusion, 1995
- Direct Fetal Administration of Immunogíobulins: Another Disappointing Therapy in Alloimmune ThrombocytopeniaFetal Diagnosis and Therapy, 1994
- Intravenous fetal transfusion of immunoglobulin for alloimmune thrombocytopeniaThe Lancet, 1992
- Antenatal Treatment of Neonatal Alloimmune ThrombocytopeniaNew England Journal of Medicine, 1988